Clinical data | |
---|---|
Trade names | Sedalipid |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H20N3O9P |
Molar mass | 393.289 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.
References
- Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. doi:10.1007/s002280000247. PMID 11317472.
Lipid-lowering agents (C10) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GI tract |
| ||||||||||||
Liver |
| ||||||||||||
Blood vessels |
| ||||||||||||
Combinations | |||||||||||||
Other | |||||||||||||
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |